| dc.contributor.author | Spoială, Augustina | |
| dc.date.accessioned | 2020-11-11T10:32:09Z | |
| dc.date.available | 2020-11-11T10:32:09Z | |
| dc.date.issued | 2020-10 | |
| dc.identifier.uri | https://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii | |
| dc.identifier.uri | https://repository.usmf.md/handle/20.500.12710/12856 | |
| dc.description | State University of Medicine and Pharmacy "Nicolae Testemiteanu" Chișinău, Republic of Moldova, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltare | en_US |
| dc.description.abstract | Introduction: MMPs are a family of proteinases that regulate cell behavior by remodeling stromal and cell surface proteins, thereby influencing cell survival, genomic stability, and differentiation. MMPs are key players in the neoplastic cells’ development and dissemination. Material and methods: In order to achieve the proposed goal, the publications from the specialized journals of the PubMed, Medline and Hinari electronic libraries have been examined. Purpose: To summarize the evidence derived from international studies on expression and involvement of metalloproteinases in the tumor growth, invasion, migration and angiogenesis to identify potential therapeutic strategies. Results: A positive correlation between tumor progression and the expression of multiple MMPs in tumor tissues has been demonstrated. There are many reports showing that members of the ADAM family are overexpressed in human cancers. Protumor activities have also been reported for ADAMTS-1 in mammary carcinomas, ADAMTS-12 in breast cancer cells, ADAMTS-4 and ADAMTS-5 in glioblastoma. Other ADAMTS metalloproteases showing tumor-associated effects are ADAMTS-2, ADAMTS-14 and ADAMTS-18. Conclusions:Altered expression of MMPs, ADAMs and ADAMTSs has been found in diverse tumor types. However, the exact role of these proteinases in the initiation or progression of the disease is generally still poorly elucidated. Specific inhibitors of ADAM could be potential remedies in anticancer therapy. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" din Republica Moldova | en_US |
| dc.subject | metalloproteases | en_US |
| dc.subject | ADAM | en_US |
| dc.subject | ADAMTS | en_US |
| dc.subject | cancer | en_US |
| dc.subject | matrix metalloproteases | en_US |
| dc.title | The role of metalloproteinases (MMPs) in tumor development | en_US |
| dc.type | Other | en_US |